AMD vs NKE: Which Is the Better Buy?

Side-by-side comparison of Advanced Micro Devices, Inc. and NIKE, Inc. β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-05-05.
Advanced Micro Devices, Inc. Β· Technology
$341.54
+38.2% upside to fair value
Grade C High Quality
VS
NIKE, Inc. Β· Consumer Cyclical
$42.62
+38.4% upside to fair value
Med Conviction Grade B+
QuantHub Verdict
NKE has more upside to fair value (+38.4%). NKE trades at a lower forward P/E (27.9x). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric AMD NKE
Current Price $341.54 $42.62
Fair Value Estimate $472.05 $58.98
Upside to Fair Value +38.2% +38.4%
Market Cap $556.9B $63.0B
Forward P/E 128.4x 27.9x
EV / EBITDA 76.3x 20.7x
Price / Sales 16.1x 1.4x
Price / FCF 82.7x 19.4x
Revenue Growth YoY +34.1% -9.8%
Gross Margin 49.5% 42.7%
Operating Margin 10.7% 8.0%
Return on Equity 7.2% 24.4%
Dividend Yield 0% 3.8%
FCF Yield 1.21% 5.2%
Analyst Consensus Buy Buy
Investment Thesis
AMD β€” Advanced Micro Devices, Inc.
Advanced Micro Devices, Inc. is a leading semiconductor company specializing in high-performance computing products including CPUs and GPUs, with a strong foothold in data center, client, gaming, and embedded markets. The company benefits from a durable competitive moat driven by its technology leadership in Zen/Ryzen CPUs and graphics processors, as well as strategic diversification through the …
NKE β€” NIKE, Inc.
Nike is the world's largest athletic footwear and apparel company with $46.3B in FY2025 revenue, operating across 190+ countries with the Nike, Jordan, and Converse brands. The stock trades near its 9-year low at $42.62 after an 11% single-day crash following a Q3 FY2026 earnings report that showed 35% net income decline and weak Q4 guidance calling for a further 2-4% revenue decline. FY2025 reve…
Accumulation Zones
Metric AMD NKE
Zone Low $354.04 $44.23
Zone High $401.24 $50.13
In Buy Zone? Yes Yes
← AMD Research    NKE Research β†’    All Research